The Pfizer Clinical Research Unit in New Haven is seeking healthy volunteers for clinical trials involving a study drug for certain types of cancer and solid tumors. These studies are designed to learn more about the study drug, its effects, and its potential use in patients.

The study drug is being evaluated for the treatment of specific cancers and solid tumors, such as breast and prostate cancer. Millions of people are diagnosed with these cancers every year. Affected patients need effective and safe treatments, and healthy volunteers are an important part of developing these medicines.

Healthy volunteers in research help scientists learn more about the specific study drug, such as how it is broken down by the body or if there are any side effects, before it is given to patients who have an active illness.

Read more about each study and how healthy volunteers can help below.

Participating in these studies

Clinical trials are the key to discovering potential new medicines that could help patients worldwide, and they are only made possible by participants.

These trials are seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:  

  • Willing to take a study drug
  • Willing and able to come to our facility in New Haven, CT*
  • Willing and able to comply with all study procedures 

There are other requirements for participation in each study. The study staff will explain these to you during the screening process.

 

Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus. 

Learn more

Condition

Healthy

Age

18-65 years

Sex

All sexes

Referral bonus

See individual study details

This information is a summary of the eligibility criteria across the studies in this program. Each study will have its own unique requirements for who may participate (eligibility criteria). To learn more about the requirements for a study that is actively recruiting, visit the study’s webpage below. Only the research study staff can determine if you qualify to enroll in the study.

Current Studies

Recruiting
Comparing Forms of Oral Study Drug for Solid Tumors
The Pfizer Clinical Research Unit is conducting a clinical trial with healthy volunteers to compare single oral doses of 2 different formulations of a study drug for specific types of solid tumors associated with cancer.

13 overnights, 1 follow-up, up to $5,950* upon completion of the study

Learn more
Recruiting
Drug Combination Study: Oral Study Drug for Solid Tumors
The Pfizer Clinical Research Unit is conducting a clinical trial with healthy volunteers to look at the effect of combining additional medications with a study drug for certain types of cancer and solid tumors.

Up to 15 overnights, 1 follow-up, up to $6,850 upon completion of the study

Learn more

Healthy participants in cancer trials

In most cases, “healthy” in clinical trials is defined as a person who does not have the condition indicated for the study drug (which in this case is cancer).

These studies include healthy volunteers to help scientists learn more about the specific study drug, such as how it is broken down by the body or if there are any side effects, before it is given to patients who have an active illness. This enables research to be done more safely, quickly, and at reduced cost compared to trials that only include patients, which ultimately helps patients once trials are completed.

It is often thought that cancer-related clinical trials are reserved for patients with severe illness or as a “last resort” due to potential risks associated with traditional therapies like chemotherapy, but this is not the case for many modern study drugs. Because of medical advancement, potential new medicines are often able to follow the same process as other non-cancer trials.

Healthy participants in cancer trials

A diverse group of people come together, holding hands in a multi-pointed star pattern with the photo taken from below.
A diverse group of people come together, holding hands in a multi-pointed star pattern with the photo taken from below.

About the Pfizer Clinical Research Unit in New Haven, CT

Many of Pfizer’s phase 1 clinical trials take place at the Pfizer Clinical Research Unit (PCRU) in New Haven, Connecticut.

Located in the heart of New Haven, our clinical research unit is a modern facility that provides study-related clinical care and monitoring of the participants in these clinical trials. The New Haven PCRU has 57 inpatient beds as well as outpatient facilities. Many of the studies include overnight stays. Within the unit, you’ll have access to internet, a large relaxation and reading area, and a multimedia room for entertainment. There is also a terrace available for fresh air and off-street parking for participants.

For more information about the PCRU – including FAQs, pictures, promotions, and participant testimonials – view the PCRU Homepage.

Interested in participating?

Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. 

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

For Japanese language assistance only, please call 1-833-711-9984. 

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.

All fields marked with * are required.

(We will do our best to contact you during this window when possible)

Cancel